Dr. Vlot has earned his PhD in molecular microbiology at Wageningen University. He specialises in the molecular mechanism of the CRISPR-Cas gene editing system and will apply his skills to our malaria drug discovery program.
Time Magazine has reported on TropIQ’s finding that veterinary drugs have the potential to protect humans from malaria, Zika, and other diseases transmitted by blood feeding insects. Read the full article here.Click here to get more information about the publication.Screen Shot 2018-07-12 at 14.18.20
Once a year malaria research groups in the Netherlands come together to share their newest results, discuss future plans and collaborative efforts. This year this event was organised and hosted by TropIQ at the Noviotech Campus. Fourteen speakers presented their cutting-edge work and sparked fruitful discussions. It was a great day of science and networking.